ENL‑102
Non‑alcoholic fatty liver disease
PreclinicalActive
Key Facts
About Enlila
Biotech startup translating Harvard metabolic research into therapies to extend health span and treat age‑related diseases.
View full company profileNon‑alcoholic fatty liver disease
Biotech startup translating Harvard metabolic research into therapies to extend health span and treat age‑related diseases.
View full company profile